Personalis, Inc. Common Stock earnings per share and revenue
On Feb 26, 2026, PSNL reported earnings of -0.26 USD per share (EPS) for Q4 25, beating the estimate of -0.29 USD, resulting in a 13.04% surprise. Revenue reached 17.34 million, compared to an expected 17.73 million, with a -2.18% difference. The market reacted with a -3.28% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 8 analysts forecast an EPS of -0.26 USD, with revenue projected to reach 14.65 million USD, implying an increase of 0.00% EPS, and decrease of -15.55% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Taysha Gene Therapies, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.08
Surprise
+18.45%
Assembly Biosciences, Inc
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.66
Actual
$2.48
Surprise
+474.06%
Sol-Gel Technologies Ltd. Ordinary Shares
Report Date
Mar 23, 2026 For Q4 25
Estimate
$0.39
Actual
-
Surprise
-
FAQ
What were Personalis, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Personalis, Inc. Common Stock reported EPS of -$0.26, beating estimates by 13.04%, and revenue of $17.34M, -2.18% below expectations.
How did the market react to Personalis, Inc. Common Stock's Q4 2025 earnings?
The stock price moved down -3.28%, changed from $8.38 before the earnings release to $8.10 the day after.
When is Personalis, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for Personalis, Inc. Common Stock's next earnings report?
Based on 8
analysts, Personalis, Inc. Common Stock is expected to report EPS of -$0.26 and revenue of $14.65M for Q1 2026.